Cargando…

Stents versus bypass surgery: 3-year mortality risk of patients with coronary interventions aged 50+ in Germany

OBJECTIVES: Due to demographic aging, the prevalence of coronary artery disease (CAD) is expected to increase in the future, resulting in a growing demand for stent and bypass interventions. This study aims to investigate the mortality risk of patients following conventional coronary artery bypass g...

Descripción completa

Detalles Bibliográficos
Autores principales: Nestler, Sophia, Kreft, Daniel, Donndorf, Peter, Ince, Hüseyin, Doblhammer, Gabriele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526318/
https://www.ncbi.nlm.nih.gov/pubmed/36183091
http://dx.doi.org/10.1186/s13019-022-02014-2
_version_ 1784800851225739264
author Nestler, Sophia
Kreft, Daniel
Donndorf, Peter
Ince, Hüseyin
Doblhammer, Gabriele
author_facet Nestler, Sophia
Kreft, Daniel
Donndorf, Peter
Ince, Hüseyin
Doblhammer, Gabriele
author_sort Nestler, Sophia
collection PubMed
description OBJECTIVES: Due to demographic aging, the prevalence of coronary artery disease (CAD) is expected to increase in the future, resulting in a growing demand for stent and bypass interventions. This study aims to investigate the mortality risk of patients following conventional coronary artery bypass grafting (CABG) or endovascular procedure by the implantation of bare-metal stents (BMS) or drug-eluting stents (DES). METHODS: Based on a random sample of 250,000 members of Germany’s largest health insurance ‘Allgemeine Ortskrankenkassen’ (AOK) from 2004 to 2015, incident CAD patients were analyzed by Cox Proportional-Hazard models. Risk adjustment was made for sex, age, other cardiac diseases, non-cardiovascular comorbidities and years since intervention. Due to later admission of DES and thus a shorter observation time, mortality was examined for 3 years since the intervention. RESULTS: BMS represented the most frequent procedure (48%). We found similar proportions of CABG (19%) and DES interventions (23%). After risk adjustment, the models showed a 21% (p = 0.004) lower mortality risk of patients with DES and also a 21% (p = 0.002) lower mortality risk of CABG patients compared to persons with BMS. CONCLUSION: Based on a large-scale dataset, our study demonstrated survival advantages of CABG and DES interventions over BMS, with no differences between the DES and CABG groups. The results help to assess the risks of coronary interventions. Aspects of quality of life, severity of postoperative physical limitations, duration of rehabilitation, patients’ preferences, and aspects of cost-effectiveness for hospitals and society should be further considered. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13019-022-02014-2.
format Online
Article
Text
id pubmed-9526318
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-95263182022-10-02 Stents versus bypass surgery: 3-year mortality risk of patients with coronary interventions aged 50+ in Germany Nestler, Sophia Kreft, Daniel Donndorf, Peter Ince, Hüseyin Doblhammer, Gabriele J Cardiothorac Surg Research Article OBJECTIVES: Due to demographic aging, the prevalence of coronary artery disease (CAD) is expected to increase in the future, resulting in a growing demand for stent and bypass interventions. This study aims to investigate the mortality risk of patients following conventional coronary artery bypass grafting (CABG) or endovascular procedure by the implantation of bare-metal stents (BMS) or drug-eluting stents (DES). METHODS: Based on a random sample of 250,000 members of Germany’s largest health insurance ‘Allgemeine Ortskrankenkassen’ (AOK) from 2004 to 2015, incident CAD patients were analyzed by Cox Proportional-Hazard models. Risk adjustment was made for sex, age, other cardiac diseases, non-cardiovascular comorbidities and years since intervention. Due to later admission of DES and thus a shorter observation time, mortality was examined for 3 years since the intervention. RESULTS: BMS represented the most frequent procedure (48%). We found similar proportions of CABG (19%) and DES interventions (23%). After risk adjustment, the models showed a 21% (p = 0.004) lower mortality risk of patients with DES and also a 21% (p = 0.002) lower mortality risk of CABG patients compared to persons with BMS. CONCLUSION: Based on a large-scale dataset, our study demonstrated survival advantages of CABG and DES interventions over BMS, with no differences between the DES and CABG groups. The results help to assess the risks of coronary interventions. Aspects of quality of life, severity of postoperative physical limitations, duration of rehabilitation, patients’ preferences, and aspects of cost-effectiveness for hospitals and society should be further considered. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13019-022-02014-2. BioMed Central 2022-10-01 /pmc/articles/PMC9526318/ /pubmed/36183091 http://dx.doi.org/10.1186/s13019-022-02014-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Nestler, Sophia
Kreft, Daniel
Donndorf, Peter
Ince, Hüseyin
Doblhammer, Gabriele
Stents versus bypass surgery: 3-year mortality risk of patients with coronary interventions aged 50+ in Germany
title Stents versus bypass surgery: 3-year mortality risk of patients with coronary interventions aged 50+ in Germany
title_full Stents versus bypass surgery: 3-year mortality risk of patients with coronary interventions aged 50+ in Germany
title_fullStr Stents versus bypass surgery: 3-year mortality risk of patients with coronary interventions aged 50+ in Germany
title_full_unstemmed Stents versus bypass surgery: 3-year mortality risk of patients with coronary interventions aged 50+ in Germany
title_short Stents versus bypass surgery: 3-year mortality risk of patients with coronary interventions aged 50+ in Germany
title_sort stents versus bypass surgery: 3-year mortality risk of patients with coronary interventions aged 50+ in germany
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526318/
https://www.ncbi.nlm.nih.gov/pubmed/36183091
http://dx.doi.org/10.1186/s13019-022-02014-2
work_keys_str_mv AT nestlersophia stentsversusbypasssurgery3yearmortalityriskofpatientswithcoronaryinterventionsaged50ingermany
AT kreftdaniel stentsversusbypasssurgery3yearmortalityriskofpatientswithcoronaryinterventionsaged50ingermany
AT donndorfpeter stentsversusbypasssurgery3yearmortalityriskofpatientswithcoronaryinterventionsaged50ingermany
AT incehuseyin stentsversusbypasssurgery3yearmortalityriskofpatientswithcoronaryinterventionsaged50ingermany
AT doblhammergabriele stentsversusbypasssurgery3yearmortalityriskofpatientswithcoronaryinterventionsaged50ingermany